Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
Contents:; Marketing Yourself as a Clinical Nurse Leader -- Integration into CNL Practice : Preparing to Lead -- Leadership Within a Complex Environment -- Microsystem Assessment and the 5P?s -- Utilizing Evidence to Improve Practice -- Utilizing Data and Quality Improvement Principles -- Coordinat…
The IARC Monographs identify environmental factors that are carcinogenic hazards to humans. These include chemicals, complex mixtures, occupational exposures, physical agents, biological agents, and lifestyle factors. National health agencies can use this information as scientific support for their…
Table of Contents:; 1. General Organizational Policies -- 2. Infection Prevention and Safety Compliance -- 3. Vascular Access Device Placement -- 4. Site Care and Maintenance -- 5. Infusion-Related Complications: Identification & Intervention -- 6. Other Infusion-Related Procedures -- 7. Other Infu…
The IARC Monographs identify environmental factors that are carcinogenic hazards to humans. These include chemicals, complex mixtures, occupational exposures, physical agents, biological agents, and lifestyle factors. National health agencies can use this information as scientific support for their…
The IARC Monographs identify environmental factors that are carcinogenic hazards to humans. These include chemicals, complex mixtures, occupational exposures, physical agents, biological agents, and lifestyle factors. National health agencies can use this information as scientific support for their…
This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 2-9 June 2015
This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 2-9 February 2016
This publication represents the views and expert; opinions of an IARC Working Group on the; Evaluation of Carcinogenic Risks to Humans which met in Lyon (France) March 2015.
c.1 BC Cancer Agency VAN Library | Available |
This publication represents the views and expert; opinions of an IARC Working Group on the; Evaluation of Carcinogenic Risks to Humans which met in Lyon (France) June 3 -10, 2014.
Table of Contents:; General organizational policies -- Infection prevention and safety compliance -- Vascular access device placement -- Site care and maintenance -- Infusion-related complications : identification & intervention -- Other infusion-related procedures -- Other infusion access -- Infus…
Table of Contents:; Chapter 1: Clinical Trials: Historical Aspects and Importance and New Drug Developments -- Chapter 2: The Definition of GCP -- Chapter 3: The Principles of GCP -- Chapter 4: The Drug Development Process and Evolution of Regulations -- Chapter 5: Planning Clinical Research -- Cha…